Anemia is defined as haemoglobin level in the blood below the lower extreme of the normal range for the age and sex of the individual. According to WHO, in developing countries the prevalence of anemia among pregnant women averages 60%, ranging between 35 to 100% among different regions of the world. A hemoglobin concentration below 11.0g/dl or packed cell volume (PCV) of less than 33.0% is regarded as anemia during pregnancy by the WHO. It occurs in 40-80% of the pregnant women. Iron and folic acid deficiencies, malaria, intestinal parasitic infections and hemoglobinopathies are the principal causes of anemia in pregnancy. Predisposing factors include young age, grand multiparity, low socioeconomic status, illiteracy, ignorance and short intervals of pregnancy. AIM AND OBJECTIVES: 1. To study various patterns of anemia in pregnant women having haemoglobin level < 11 gm%. 2. To determine the most common pattern of anemia in pregnancy based on red cell morphology. MATERIALS AND METHODS: This study is a prospective study over a period of one year from September 2014 to August 2015 in the department of pathology, Andhra medical college, Visakhapatnam. The study was conducted on 120 pregnant women whose haemoglobin level is <11 gm/dl. All the haemotological parameters & peripheral blood smear stained by Leishman's stain were evaluated. Complete clinical & obstetric history was recorded. Socioeconomic status was also noted. RESULTS: Out of 120 cases of anemia, we found 47 patients (39.1%) having dimorphic anemia, 36(30%)-microcytic hypochromic anemia, 23(19.1%)-normocytic hypochromic anemia, 11(9.16%)-sickle cell anemia and 1(0.83%) case of pancytopenia. Maximum cases were seen in the age group of 21-30 years. 52 cases (43.3%) were primigravida and remaining 68 cases (56.6%) were gravida two to four. 20 cases (16.6%) were diagnosed in the first trimester, 38 cases (31.6%) in the second trimester & 62 cases (51.6s%) in the third trimester. CONCLUSION: In conclusion, the common morphological patterns of anemia in this study are dimorphic anemia and microcytic hypochromic anemia. More common in the multigravida & in the third trimester of pregnancy. After the 1 st trimester there is increased fetal demand & hemodilution effect and thus anemia occurs commonly in this period. The risk factors for anemia in this study are low socioeconomic status, multiparity & H/O complications during previous pregnancy. The socioeconomic conditions must be improved, early detection & good antenatal care to be provided for the prevention of anemia in pregnancy.
No abstract
I / we hereby certify that I / we have participated sufficiently in the intellectual content, conception and design of this work or the analysis and interpretation of the data as well as the writing of the manuscript, to take public responsibility for it and have agreed to have our name listed as a contributor. I / we believe the manuscript represents valid work. Each author confirms they meet the criteria for authorship as established by the ICMJE. Neither this manuscript nor one with substantially similar content under my / our authorship has been published or is being considered for publication elsewhere, except as described in the covering letter. I / we certify that all the data collected during the study is presented in this manuscript and no data from the study has been or will be published separately. I / we attest that, if requested by the editors, I / we will provide the data / information or will cooperate fully in obtaining and providing the data / information on which the manuscript is based, for examination by the editors or their assignees. Financial interests, direct or indirect, that exist or may be perceived to exist for individual contributors in connection with the content of this paper have been disclosed in the cover letter. Sources of outside support of the project are named in the cover letter. I / we hereby transfer(s), assign(s), or otherwise convey (s) all copyright ownership, including any and all rights incidental thereto, exclusively to the Journal, in the event that such is published by the Journal. The Journal shall own the work, including 1) copyright; 2) the right to grant permission to republish the article in whole or in part, with or without fee; 3) the right to produce preprints or reprints and translate into languages other than English for sale or free distribution; and 4) the right to republish the work in a collection of articles in any other mechanical or electronic format. I / we give the rights to the corresponding author to make necessary changes as per the request of the Journal, do the rest of the corresponding on our behalf and will act as the guarantor for the manuscript on our behalf. The article will be publish under the terms of the national and international copyrights grants to all user a free irrevocable worldwide, perpetual right of access to a license to copy user, distribute, perform and display the work publicly and to make and distribute derivate works in any digital medium for any reasonable non-commercial purpose and latest Creative Commons Attribution 4.0 International (CC BY 4.0).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.